Published online Dec 6, 2025. doi: 10.12998/wjcc.v13.i34.111732
Revised: September 14, 2025
Accepted: November 18, 2025
Published online: December 6, 2025
Processing time: 146 Days and 22.5 Hours
The frequent occurrence of respiratory diseases in the island reef environment of the navy severely affects the health of personnel and the combat effectiveness of the troops. Current common screening methods can only indicate whether there is an infection with pathogenic microorganisms but not the degree of disease prog
To explores correlation between serum concentrations of nicotinamide phosphoribosyltransferase (NAMPT), nicotinamide nucleotide adenylyltransferase 1 (NMNAT1), and the risk of upper respiratory infections in the island reef envir
A total of 600 cases of upper respiratory infections among naval officers and soldiers were included. Types of infection were confirmed through sputum cult
The serum concentrations of NAMPT and NMNAT1 in high-risk group patients with PSI were significantly lower than those in the medium and low-risk groups (P < 0.05), and the concentrations increased in a stepwise manner with disease progression. However, within the same risk group, the differences in concentrations of NAMPT and NMNAT1 among patients infected with different pathogens were not significant (P > 0.05).
Concentrations of NAMPT and NMNAT1 are closely related to severity of upper respiratory infections, and their common regulatory mechanisms provide new directions for development of broad-spectrum anti-infection strategies.
Core Tip: This study investigated the correlation between five common respiratory pathogens in the ship environment (influenza H1N1 virus, influenza B virus, Streptococcus pneumoniae, adenovirus, and severe acute respiratory syndrome coronavirus 2) and the severity of upper respiratory tract infections in patients, as well as serum concentrations of nicotinamide phosphoribosyltransferase (NAMPT) and nicotinamide nucleotide adenylyltransferase 1 (NMNAT1). We analyzed the feasibility of using NAMPT and NMNAT1 concentrations as potential biomarkers for assessing the severity of upper respiratory tract infections, providing a basis for clinical diagnosis and treatment of personnel stationed on ships and islands.
